Talaris Therapeutics, Inc and Tourmaline Bio, Inc. , a late-stage clinical biotechnology company developing transformative medicines, announced that the companies have entered into a definitive agreement under which Tourmaline will combine with Talaris in an all-stock transaction. The proposed…